Group 1 - Apyx Medical Corporation will release its financial results for the fourth quarter and fiscal year 2024 on March 13, 2025, before the market opens [1] - A conference call will be held on the same day at 8:30 a.m. Eastern Time to discuss the financial results and include a question-and-answer session [2] - The company specializes in advanced energy technology, particularly its proprietary helium plasma and radiofrequency technology marketed as Renuvion and J-Plasma [3] Group 2 - Renuvion and J-Plasma provide surgeons with the ability to deliver controlled heat to tissue, supported by over 90 clinical documents [3] - Apyx Medical has established OEM agreements with other medical device manufacturers, leveraging its expertise in unique waveforms [3]
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2024 Financial Results on March 13, 2025